JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.37, ss.1198-1202, 2011 (SCI İndekslerine Giren Dergi)
Aims: Increasing evidence supports the participation of metabolic syndrome and insulin resistance in the pathogenesis of pre-eclampsia. Copeptin is co-synthesized with vasopressin and is a new and promising novel marker of metabolic syndrome and insulin resistance. Our aim was to investigate copeptin levels in normotensive pregnant, mild and severe pre-eclamptic women.